Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected] Learn more

GFP-p53 Citations (32)

Plasmid Article: An intact HDM2 RING-finger domain is required for nuclear exclusion of p53.
Boyd SD, Tsai KY, Jacks T Nat Cell Biol. 2000 Sep . 2(9):563-8.
PubMed Journal

Articles Citing GFP-p53

Articles
USP10 regulates p53 localization and stability by deubiquitinating p53. Yuan J, Luo K, Zhang L, Cheville JC, Lou Z. Cell. 2010 Feb 5;140(3):384-96. doi: 10.1016/j.cell.2009.12.032. Epub 2010 Jan 21. PubMed
A novel cancer targeting approach based on estrone anchored stealth liposome for site-specific breast cancer therapy. Paliwal SR, Paliwal R, Mishra N, Mehta A, Vyas SP. Curr Cancer Drug Targets. 2010 May;10(3):343-53. PubMed
Heterogeneity in the kinetics of nuclear proteins and trajectories of substructures associated with heterochromatin. Stixova L, Bartova E, Matula P, Danek O, Legartova S, Kozubek S. Epigenetics Chromatin. 2011 Mar 18;4:5. doi: 10.1186/1756-8935-4-5. PubMed
Hepatitis B virus core promoter mutations contribute to hepatocarcinogenesis by deregulating SKP2 and its target, p21. Huang Y, Tong S, Tai AW, Hussain M, Lok AS. Gastroenterology. 2011 Oct;141(4):1412-21, 1421.e1-5. doi: 10.1053/j.gastro.2011.06.048. Epub 2011 Jun 24. PubMed
Cyclohexylmethyl Flavonoids Suppress Propagation of Breast Cancer Stem Cells via Downregulation of NANOG. Liao WY, Liaw CC, Huang YC, Han HY, Hsu HW, Hwang SM, Kuo SC, Shen CN. Evid Based Complement Alternat Med. 2013;2013:170261. doi: 10.1155/2013/170261. Epub 2013 Apr 4. PubMed
The clinical potential of targeted nanomedicine: delivering to cancer stem-like cells. Kim SS, Rait A, Rubab F, Rao AK, Kiritsy MC, Pirollo KF, Wang S, Weiner LM, Chang EH. Mol Ther. 2014 Feb;22(2):278-91. doi: 10.1038/mt.2013.231. Epub 2013 Oct 11. PubMed
Visualization and targeted disruption of protein interactions in living cells. Herce HD, Deng W, Helma J, Leonhardt H, Cardoso MC. Nat Commun. 2013;4:2660. doi: 10.1038/ncomms3660. PubMed
A miR-199a/miR-214 self-regulatory network via PSMD10, TP53 and DNMT1 in testicular germ cell tumor. Chen BF, Suen YK, Gu S, Li L, Chan WY. Sci Rep. 2014 Sep 18;4:6413. doi: 10.1038/srep06413. PubMed
Targeting the DNA replication checkpoint by pharmacologic inhibition of Chk1 kinase: a strategy to sensitize APC mutant colon cancer cells to 5-fluorouracil chemotherapy. Martino-Echarri E, Henderson BR, Brocardo MG. Oncotarget. 2014 Oct 30;5(20):9889-900. PubMed
Co-delivery of plasmid DNA and antisense oligodeoxyribonucleotide into human carcinoma cells by cationic liposomes. Weecharangsan W, Opanasopit P, Yingyongnarongkul BE, Kewsuwan P, Lee RJ. Curr Pharm Biotechnol. 2014;15(9):790-9. PubMed
Prevalence and functional consequence of TP53 mutations in pediatric adrenocortical carcinoma: a children's oncology group study. Wasserman JD, Novokmet A, Eichler-Jonsson C, Ribeiro RC, Rodriguez-Galindo C, Zambetti GP, Malkin D. J Clin Oncol. 2015 Feb 20;33(6):602-9. doi: 10.1200/JCO.2013.52.6863. Epub 2015 Jan 12. PubMed
HP1beta-dependent recruitment of UBF1 to irradiated chromatin occurs simultaneously with CPDs. Stixova L, Sehnalova P, Legartova S, Suchankova J, Hruskova T, Kozubek S, Sorokin DV, Matula P, Raska I, Kovarik A, Fulnecek J, Bartova E. Epigenetics Chromatin. 2014 Dec 30;7(1):39. doi: 10.1186/1756-8935-7-39. eCollection 2014. PubMed
A High-Throughput Cell-Based Screen Identified a 2-[(E)-2-Phenylvinyl]-8-Quinolinol Core Structure That Activates p53. Bechill J, Zhong R, Zhang C, Solomaha E, Spiotto MT. PLoS One. 2016 Apr 28;11(4):e0154125. doi: 10.1371/journal.pone.0154125. eCollection 2016. PubMed
The tumour suppressor CYLD regulates the p53 DNA damage response. Fernandez-Majada V, Welz PS, Ermolaeva MA, Schell M, Adam A, Dietlein F, Komander D, Buttner R, Thomas RK, Schumacher B, Pasparakis M. Nat Commun. 2016 Aug 26;7:12508. doi: 10.1038/ncomms12508. PubMed
Pre-operative in vitro fibroblast coating of porous polyethylene compound grafts - Cell survival in vivo and effects on biocompatibility. Hussain T, Schneider M, Summer B, Strieth S. Biomed Mater Eng. 2016 Aug 12;27(2-3):237-49. doi: 10.3233/BME-161579. PubMed
Snail1-dependent p53 repression regulates expansion and activity of tumour-initiating cells in breast cancer. Ni T, Li XY, Lu N, An T, Liu ZP, Fu R, Lv WC, Zhang YW, Xu XJ, Grant Rowe R, Lin YS, Scherer A, Feinberg T, Zheng XQ, Chen BA, Liu XS, Guo QL, Wu ZQ, Weiss SJ. Nat Cell Biol. 2016 Nov;18(11):1221-1232. doi: 10.1038/ncb3425. Epub 2016 Oct 17. PubMed
OSU-2S/Sorafenib Synergistic Antitumor Combination against Hepatocellular Carcinoma: The Role of PKCdelta/p53. Omar HA, Tolba MF, Hung JH, Al-Tel TH. Front Pharmacol. 2016 Nov 30;7:463. eCollection 2016. PubMed
The ubiquitin ligase LIN41/TRIM71 targets p53 to antagonize cell death and differentiation pathways during stem cell differentiation. Nguyen DTT, Richter D, Michel G, Mitschka S, Kolanus W, Cuevas E, Gregory Wulczyn F. Cell Death Differ. 2017 Jun;24(6):1063-1078. doi: 10.1038/cdd.2017.54. Epub 2017 Apr 21. PubMed
p53 amyloid formation leading to its loss of function: implications in cancer pathogenesis. Ghosh S, Salot S, Sengupta S, Navalkar A, Ghosh D, Jacob R, Das S, Kumar R, Jha NN, Sahay S, Mehra S, Mohite GM, Ghosh SK, Kombrabail M, Krishnamoorthy G, Chaudhari P, Maji SK. Cell Death Differ. 2017 Oct;24(10):1784-1798. doi: 10.1038/cdd.2017.105. Epub 2017 Jun 23. PubMed
The Combination of Metformin and Valproic Acid Induces Synergistic Apoptosis in the Presence of p53 and Androgen Signaling in Prostate Cancer. Tran LNK, Kichenadasse G, Butler LM, Centenera MM, Morel KL, Ormsby RJ, Michael MZ, Lower KM, Sykes PJ. Mol Cancer Ther. 2017 Dec;16(12):2689-2700. doi: 10.1158/1535-7163.MCT-17-0074. Epub 2017 Aug 11. PubMed
A General Strategy for Discovery of Inhibitors and Activators of RING and U-box E3 Ligases with Ubiquitin Variants. Gabrielsen M, Buetow L, Nakasone MA, Ahmed SF, Sibbet GJ, Smith BO, Zhang W, Sidhu SS, Huang DT. Mol Cell. 2017 Oct 19;68(2):456-470.e10. doi: 10.1016/j.molcel.2017.09.027. PubMed
Synergistic Inhibition of Human Carcinoma Cell Growth via Co-Delivery of p53 Plasmid DNA and bcl-2 Antisense Oligodeoxyribonucleotide by Cholic Acid-modified Polyethylenimine. Weecharangsan W, Opanasopit P, Niyomtham N, Yingyongnarongkul BE, Kewsuwan P, Lee RJ. Anticancer Res. 2017 Nov;37(11):6335-6340. doi: 10.21873/anticanres.12085. PubMed
Nuclear p53-mediated repression of autophagy involves PINK1 transcriptional down-regulation. Goiran T, Duplan E, Rouland L, El Manaa W, Lauritzen I, Dunys J, You H, Checler F, Alves da Costa C. Cell Death Differ. 2018 Jan 19. pii: 10.1038/s41418-017-0016-0. doi: 10.1038/s41418-017-0016-0. PubMed
MYCN acts as a direct co-regulator of p53 in MYCN amplified neuroblastoma. Agarwal S, Milazzo G, Rajapakshe K, Bernardi R, Chen Z, Barberi E, Koster J, Perini G, Coarfa C, Shohet JM. Oncotarget. 2018 Apr 17;9(29):20323-20338. doi: 10.18632/oncotarget.24859. eCollection 2018 Apr 17. PubMed
A regulatory circuitry comprising TP53, miR-29 family, and SETDB1 in non-small cell lung cancer. Chen B, Wang J, Wang J, Wang H, Gu X, Tang L, Feng X. Biosci Rep. 2018 Sep 13;38(5). pii: BSR20180678. doi: 10.1042/BSR20180678. Print 2018 Oct 31. PubMed
Sonoporation by microbubbles as gene therapy approach against liver cancer. Rinaldi L, Folliero V, Palomba L, Zannella C, Isticato R, Di Francia R, Berretta M, de Sio I, Adinolfi LE, Morelli G, Lastoria S, Altucci L, Pedone C, Galdiero M, Franci G. Oncotarget. 2018 Aug 14;9(63):32182-32190. doi: 10.18632/oncotarget.25875. eCollection 2018 Aug 14. PubMed
Activation-induced deaminase (AID) localizes to the nucleus in brief pulses. Le Q, Maizels N. PLoS Genet. 2019 Feb 27;15(2):e1007968. doi: 10.1371/journal.pgen.1007968. eCollection 2019 Feb. PubMed
The atypical cyclin-like protein Spy1 overrides p53-mediated tumour suppression and promotes susceptibility to breast tumourigenesis. Fifield BA, Qemo I, Kirou E, Cardiff RD, Porter LA. Breast Cancer Res. 2019 Dec 11;21(1):140. doi: 10.1186/s13058-019-1211-3. PubMed
Thiol antioxidants sensitize malabaricone C induced cancer cell death via reprogramming redox sensitive p53 and NF-kappaB proteins in vitro and in vivo. Tyagi M, Bauri AK, Chattopadhyay S, Patro BS. Free Radic Biol Med. 2020 Feb 20;148:182-199. doi: 10.1016/j.freeradbiomed.2020.01.011. Epub 2020 Jan 13. PubMed
Recruitment of Host Nuclear Pore Components to the Vicinity of Theileria Schizonts. Huber S, Bar A, Epp S, Schmuckli-Maurer J, Eberhard N, Humbel BM, Hemphill A, Woods K. mSphere. 2020 Feb 5;5(1). pii: 5/1/e00709-19. doi: 10.1128/mSphere.00709-19. PubMed
A rapid solubility assay of protein domain misfolding for pathogenicity assessment of rare DNA sequence variants. Anderson CL, Routes TC, Eckhardt LL, Delisle BP, January CT, Kamp TJ. Genet Med. 2020 Jun 1. pii: 10.1038/s41436-020-0842-1. doi: 10.1038/s41436-020-0842-1. PubMed
Subcellular Distribution of p53 by the p53-Responsive lncRNA NBAT1 Determines Chemotherapeutic Response in Neuroblastoma. Mitra S, Muralidharan SV, Marco MD, Juvvuna PK, Kosalai ST, Reischl S, Jachimowicz D, Subhash S, Raimondi I, Kurian L, Huarte M, Kogner P, Fischer M, Johnsen JI, Mondal T, Kanduri C. Cancer Res. 2021 Mar 15;81(6):1457-1471. doi: 10.1158/0008-5472.CAN-19-3499. Epub 2020 Dec 28. PubMed

If you have published an article using this plasmid, please email us at [email protected] to have your article added to this page.